Repligen Corp

Organisation

Building 1, Waltham, MA, United States, 02453

Headquarters

2000

Employees

Health Technology

Industry

Anthony Hunt

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Price

Target

Repligen Corp (RGEN) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Repligen Corp (RGEN) share price will touch around $186.82 in next 12-months.

Currently 19 wall-street analysts regularly analyze the financials of Repligen Corp on a frequent basis to provide recommendations along with target share price. 19 analysts offering 12-month price forecasts for Repligen Corp (RGEN) have a share price target of $186.82. This median of share price forecast represents a 58.5% upside from the latest price of $117.87 as on 03.04.26.

Repligen Corp (RGEN) Share Price Forecast

Home

US Stocks

Repligen Corp (RGEN)

Repligen Corp Stock Forecast

Repligen Corp Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Repligen Corp (RGEN): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Repligen Corp's share price and its median forecast price. As on 03.04.26, the difference is -36.67%

Repligen Corp Forecast and Target Price

Repligen Corp (RGEN) Share Price Forecast

Repligen Corp (RGEN) Price vs Consensus Price Target

Repligen Corp (RGEN) Share Price Forecast v/s Share Price Today

Repligen Corp (RGEN): Difference between Current Price & Median Forecasted Price

Repligen Corp (RGEN) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price